208 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
Clinical Trials of SGLT2 ... ASCVD; signal for SGLT2i ... risk; signal for SGLT2i ... mcclaffertyMD #SGLT2 ... inhibitors #EBM #trial #visualabstract
How SGLT2 inhibitors block glucose reabsorption in proximal tubule and improve systemic glucose homeostasis:
https://www.ajkd.org/article/S0272-6386(18)30633-4/fulltext

#Pathophysiology #Mechanism #Nephrology
How SGLT2 inhibitors ... Pathophysiology #Mechanism #Nephrology ... #SLGT2 #Inhibitors
#SGLT2i #patientinfo #nephrology
#SGLT2i #patientinfo ... #nephrology
#visualabstract #sglt2i #nephrology
#visualabstract ... #sglt2i #nephrology
#VisualAbstract for #Lancet trial #CANVASR #SGLT2i #Canagliflozin

"Canagliflozin and renal outcomes in type 2 diabetes: results from
#VisualAbstract ... trial #CANVASR #SGLT2i
Renal diseases associated with endothelial injury@NatRevNeph
#hemolyticuremicsyndrome #lupusnephritis #anca #Visualabstract #nephrology
lupusnephritis #anca #Visualabstract ... #nephrology
#visualabstract #nephrology #copeptin #diabetesinsipidus #NEJM
A Copeptin based approach to diagnose Diabetes insipidus
#visualabstract ... #nephrology #copeptin
Diabetic Nephropathy - Timeline of Important Trials

Dr. Lovy Gaur https://twitter.com/drlovygaur

#Diabetic #Nephropathy #EBM #VisualAbstract #Trials #Nephrology #Timeline
Nephropathy #EBM #VisualAbstract ... #Trials #Nephrology
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
drugs Other than SGLT2i ... receptor agonist SGLT2i ... #CKD #Diabetes Management ... in CKD #management
Stepwise Approach to Prescription of SGLT2 inhibitors 

Anticipatory Guidance 
• Consider diuretic dose reduction 
Patient Counseling
Prescription of SGLT2 ... endocrinologists #SGLT2 ... Prescribing #Monitoring #Management